These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12900211)

  • 1. Retroviral gene therapy--where now?
    Günzburg WH
    Trends Mol Med; 2003 Jul; 9(7):277-8. PubMed ID: 12900211
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukemia case triggers tighter gene-therapy controls.
    Bonetta L
    Nat Med; 2002 Nov; 8(11):1189. PubMed ID: 12411927
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gene therapy for severe combined immunodeficiency linked to chromosome X].
    Fischer A
    Hematol Cell Ther; 1997 Apr; 39(2):97. PubMed ID: 9229544
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gene therapy using retroviral vectors].
    Hanawa H; Shimada T
    Uirusu; 2003 Dec; 53(2):177-83. PubMed ID: 15071956
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene therapy for primary immunodeficiencies.
    Fischer A; Hacein-Bey Abina S; Touzot F; Cavazzana M
    Clin Genet; 2015 Dec; 88(6):507-15. PubMed ID: 25708106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A voluntary moratorium?
    Verma IM
    Mol Ther; 2003 Feb; 7(2):141. PubMed ID: 12638540
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: improved retroviral vectors for clinical trials.
    Onodera M; Nelson DM; Sakiyama Y; Candotti F; Blaese RM
    Acta Haematol; 1999; 101(2):89-96. PubMed ID: 10202239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful gene therapy for severe combined immunodeficiency.
    Rosen FS
    N Engl J Med; 2002 Apr; 346(16):1241-3. PubMed ID: 11961154
    [No Abstract]   [Full Text] [Related]  

  • 9. [Safety of retroviral vectors in gene therapy].
    Bogoslovskaia EV; Glazkova DV; Shipulin GA; Pokrovskiĭ VV
    Vestn Ross Akad Med Nauk; 2012; (10):55-61. PubMed ID: 23240501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy of X-linked severe combined immunodeficiency.
    Hacein-Bey-Abina S; de Saint Basile G; Cavazzana-Calvo M
    Methods Mol Biol; 2003; 215():247-59. PubMed ID: 12512304
    [No Abstract]   [Full Text] [Related]  

  • 11. ADA-SCID Gene Therapy Endorsed By European Medicines Agency For Marketing Authorization.
    Ylä-Herttuala S
    Mol Ther; 2016 Jun; 24(6):1013-1014. PubMed ID: 27324442
    [No Abstract]   [Full Text] [Related]  

  • 12. Investor Outlook: Rising from the Ashes; GSK's European Approval of Strimvelis for ADA-SCID.
    Schimmer J; Breazzano S
    Hum Gene Ther Clin Dev; 2016 Jun; 27(2):57-61. PubMed ID: 27267267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transduction events in retrovirus-mediated gene therapy involving hematopoietic stem cells: beyond efficiency issues.
    Medin JA; Fowler DH
    J Cell Biochem Suppl; 2002; 38():46-54. PubMed ID: 12046849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy of severe combined immunodeficiencies.
    Fischer A; Hacein-Bey S; Le Deist F; De Saint Basile G; Cavazzana-Calvo M
    Adv Exp Med Biol; 2001; 495():199-204. PubMed ID: 11774567
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gene therapy and clinical trials].
    Tazawa R; Pradono P; Hagiwara K; Nukiwa T
    Nihon Rinsho; 2002 May; 60 Suppl 5():625-9. PubMed ID: 12101750
    [No Abstract]   [Full Text] [Related]  

  • 16. Retroviral vector for gene therapy of X-linked severe combined immunodeficiency syndrome.
    Qazilbash MH; Walsh CE; Russell SM; Noguchi M; Mann MM; Leonard WJ; Liu JM
    J Hematother; 1995 Apr; 4(2):91-8. PubMed ID: 7633846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.
    Hacein-Bey-Abina S; von Kalle C; Schmidt M; Le Deist F; Wulffraat N; McIntyre E; Radford I; Villeval JL; Fraser CC; Cavazzana-Calvo M; Fischer A
    N Engl J Med; 2003 Jan; 348(3):255-6. PubMed ID: 12529469
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene therapy for SCID--a complication after remarkable progress.
    Buckley RH
    Lancet; 2002 Oct; 360(9341):1185-6. PubMed ID: 12401240
    [No Abstract]   [Full Text] [Related]  

  • 19. Gene therapy. Second child in French trial is found to have leukemia.
    Marshall E
    Science; 2003 Jan; 299(5605):320. PubMed ID: 12531981
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.
    McCormack MP; Rabbitts TH
    N Engl J Med; 2004 Feb; 350(9):913-22. PubMed ID: 14985489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.